Why is Medico Remedies falling/rising?

As of 09-Jul, Medico Remedies Ltd's stock price is currently at 42.03, reflecting an increase of 0.49 or 1.18%. The stock has shown a trend reversal by gaining after two consecutive days of decline, outperforming its sector by 0.98%. However, despite this recent uptick, the stock has a mixed performance over different periods, with a 1-week return of +3.47% but a significant decline of -17.25% over the past month. The company has a strong ability to service debt, indicated by a low Debt to EBITDA ratio of 0.94 times, and has reported positive results for March 25, with a notable growth in profit before tax and operating profit margins. Nonetheless, the stock's valuation appears expensive with a ROCE of 16.1 and a high enterprise value to capital employed ratio of 4.8, which may deter some investors.
In the broader market context, Medico Remedies' recent performance contrasts with the Sensex, which has only increased by 0.15% over the past week. The stock's declining delivery volume, which has fallen by 76.38% against the 5-day average, suggests a decrease in investor participation, potentially reflecting reduced confidence among investors. Additionally, the promoters have decreased their stake by 3.04% in the last quarter, which could signal waning confidence in the company's future prospects. While the stock has generated a return of 5.10% over the past year, its profits have risen by 21.6%, leading to a PEG ratio of 1.6, indicating that the stock may be trading at a discount compared to its peers' historical valuations.